Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

NCT04958265

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • University of Nebraska Omaha, Nebraska, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • UZ Gent Ghent, Belgium
View all 20 locations
View Trial Details
Active, Not Recruiting

Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma

NCT03236428

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Pacific Cancer Care Monterey, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma

NCT04756726

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +20 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • University of California-San Francisco San Francisco, California, United States
  • Colorado Blood Cancer Institute (Sarah Cannon Research Institute) Denver, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)

NCT02586857

Conditions
Astrocytoma, Chronic Disease, Disease Attributes, +22 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Palo Alto, California, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Study of ACP-196 (Acalabrutinib) in Subjects With Relapsed/Refractory CLL and Intolerant of Ibrutinib Therapy

NCT02717611

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Concord, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Palo Alto, California, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Hematologic Malignancies

NCT06645886

Conditions
Adult, Hematologic Diseases, Hematologic Malignancies, +4 more
Locations
  • University of California, San Francisco (UCSF) San Francisco, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma

NCT04268498

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Miami Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions